Publications

The CDPE adheres to the highest standards of peer-reviewed scientific research and all research products are externally peer-reviewed by scientists or via leading scientific journals. To request a copy of any publication that is not open access, please email info@cdpe.org.

as part of Policy Impact Unit

In this brief for the Biden-Harris Administration, the CDPE and the Health in Justice Action Lab outline key actions to enhance the equity and effectiveness of drug policy in the United States.

View publication

as part of Toronto’s Drug Checking Service

Between January 1 and December 31, 2020, 1657 samples were checked using mass spectrometry technologies (gas- and liquid-chromatography). This report details the results from the analysis of those samples.

View publication

as part of Toronto’s Drug Checking Service

The objective of this study was to characterise the presence of synthetic cannabinoids in the unregulated drug supply in three Canadian settings.

View publication

as part of Preventing Injecting by Modifying Existing Responses (PRIMER)

Using mixed methods across three settings in North America, we investigated the gender composition of injection initiation events and the gendered risk environments in which they occurred.

View publication

as part of Integrated Supervised Injection Services Evaluation in Toronto, Ontario

This study examined associations between SCS use and non-fatal overdose among PWID in Toronto, Ontario, Canada amidst the current opioid overdose epidemic, drawing on baseline data from a cohort of PWID including individuals who do and do not use SCS.

View publication

as part of COVID-19 Rapid Assessment

The Ontario Drug Policy Research Network, the Office of the Chief Coroner for Ontario/the Ontario Forensic Pathology Service, Public Health Ontario, and the CDPE have published a report analyzing trends in opioid-related deaths and comparing circumstances of death between two groups: a COVID-19 pandemic cohort and a pre-pandemic cohort.

View publication

as part of Policy Impact Unit

The aim of this project was to examine the race and gender of c-suite level executives and boards of directors of licensed cannabis producers and their parent companies operating in the Canadian cannabis industry, in order to assess whether the promise of an equitable legal cannabis market has been achieved.

View publication

as part of Systematic Reviews on Drug Policy

Given increasing interest in quantifying the impact of drug law reform, as well as a lack of systematic assessment of outcomes beyond adolescent cannabis use to date, we conducted a systematic review of original peer-reviewed research evaluating the impacts of (a) legal regulation and (b) drug decriminalisation on drug availability, use or related health and social harms. Our primary aim is to characterise studies with respect to metrics and indicators used. The secondary aim is to summarise the findings and methodological quality of studies to date.

View publication

as part of Drug Policy Metrics Map

Analysing arguably one of the most contested areas in public policy, this pioneering Research Handbook brings together contributions from a variety of researchers and practitioners to provide a global overview of the shifting dynamics of drug policy.

View publication

Published: July 1, 2020 as part of Preventing Injecting by Modifying Existing Responses (PRIMER)

Given the prevalence and harms of incarceration among persons who inject drugs (PWID) and their role in injection drug use initiation, this study aimed to investigate whether recent incarceration influences the likelihood PWID assist others in their first-ever injection.

View publication
Page 1 of 5